Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pediatric Hypochondriasis Differential Diagnoses

  • Author: Maria Sandra Cely-Serrano, MD; Chief Editor: Caroly Pataki, MD  more...
 
Updated: Mar 19, 2015
 
 

Diagnostic Considerations

The differential diagnosis of somatoform disorders and hypochondriasis should consider any possible medical or psychiatric illness. Somatoform disorders or hypochondriasis can occur concurrently with medical or psychiatric illnesses. Also, according to the DSM-IV, psychological factors affecting a medical condition imply the presence of a general medical illness.

Medical Illnesses

Patients with medical conditions with an insidious or long-term progression (eg, multiple sclerosis, hemiplegic migraine) may present with a somatoform disorder. These medical conditions have repeated, nonspecific signs and symptoms that could be interpreted as a somatoform disorder. In hemiplegic migraine, patients present with hemiplegia or hemiparesis, with or without a speech and/or language disturbance, which clears in minutes to hours. Diagnosis can be made with repeated, stereotyped episodes and complete clearing between episodes, particularly in the presence of a positive family history. In multiple sclerosis, patients have multiple symptoms that are difficult to describe initially, but the symptoms resolve subsequently. The symptoms affect different parts of the body at different times.

Patients with organic brain disorders, such as delirium or dementia of any etiology (eg, toxic, metabolic, infectious), can present with somatic symptoms.

Psychiatric Illnesses

Other somatoform disorders

Conversion disorder is the presence of symptoms or deficits in sensory or motor function that indicate an organic medical or neurologic disorder, apparently due to stress or psychological issues. Symptoms are nonintentional and have no evident pathophysiology. Most frequent symptoms are neurologic in origin (eg, blindness, seizures, paralysis, seizures).

Pain disorder is the presence of pain with no explainable etiology; the 2 types are (1) predominant psychological pain and (2) a combination of psychological factors with a medical condition.

Body dysmorphic disorder is an imagined structural defect in a person who appears normal to the expert observer.

Affective disorders

Patients with depression or mania can present with multiple symptoms such as change of appetite and sleep patterns. Depression and hypochondriasis may overlap, especially when the morbid ideation of depression takes the form of disease phobias.

Anxiety disorders

The most common symptoms in children with anxiety disorder are headaches, stomachaches, nausea, and vomiting. Symptoms are often associated with an anxiety-provoking situation.

Hypochondriasis and panic disorder are both characterized by prevalent health anxieties and illness beliefs. Panic patients have more comorbidity with agoraphobia while hypochondriac patients are more closely associated with somatization. Patients with hypochondriasis plus panic have higher levels of anxiety, more somatization, more general psychopathology, and a trend towards increased health care utilization.

Psychoses

Psychosis can be differentiated by involvement of thought processes, social withdrawal, and impaired functioning.

Obsessive-compulsive disorders

Patients with obsessive-compulsive disorder and/or hypochondriasis often share the comorbidity of intense fears of illness, injury, or contamination. The lifetime prevalence of obsessive-compulsive disorders in a series of adult patients with hypochondriasis was 4 times more than in a comparison group (ie, 8% versus 2%). In contrast to those with hypochondriasis, patients with obsessive-compulsive disorder view their fears as abnormal, attempt to suppress them, and avoid publicizing their symptoms, which are frequently observed as shameful.

Personality disorders

A high prevalence of personality disorders is noted in patients with hypochondriasis, particularly obsessive compulsive disorder (OCD). In one study, 76.5% from a total of 88 patients with hypochondriasis had OCD.[13] This suggests that consideration of personality features is important in assessment and therapeutic interventions for hypochondriasis.

Malingering and Factitious Disorders

Malingering is the intentional production of symptoms or signs of illness or disability in order to obtain a specific goal (eg, avoiding school, acquiring drugs or money).

Factitious disorder is the intentional production of symptoms to maintain a nonspecific patient role (eg, maintaining a dependency role in the family over time).

In somatoform disorders, symptoms are not produced voluntarily, thus differing from factitious disorders and malingering in which symptoms are produced intentionally.

Adolescents who present with unexplained neurologic symptoms in the primary care setting may be suffering from a clinically significant behavioral health disorder or some other form of psychological distress. If no adequate medical cause can be found to explain the patient's presenting symptomatology, it is important for the primary care provider to conduct a careful assessment of the patient's psychosocial functioning.

 
 
Contributor Information and Disclosures
Author

Maria Sandra Cely-Serrano, MD Developmental and Behavioral Pediatrician, Center for Child Development, Florida Hospital

Maria Sandra Cely-Serrano, MD is a member of the following medical societies: American Academy of Pediatrics, Society for Developmental and Behavioral Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

Caroly Pataki, MD Health Sciences Clinical Professor of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Caroly Pataki, MD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry, New York Academy of Sciences, Physicians for Social Responsibility

Disclosure: Nothing to disclose.

Additional Contributors

Angelo P Giardino, MD, MPH, PhD Professor and Section Head, Academic General Pediatrics, Baylor College of Medicine; Senior Vice President and Chief Quality Officer, Texas Children’s Hospital

Angelo P Giardino, MD, MPH, PhD is a member of the following medical societies: Academic Pediatric Association, American Academy of Pediatrics, American Professional Society on the Abuse of Children, Harris County Medical Society, International Society for the Prevention of Child Abuse and Neglect, Ray E Helfer Society

Disclosure: Received grant/research funds from Health Resources and Services Administration (HRSA) Integrated Community Systems for CSHCN Grant for other; Received advisory board from Baxter Healthcare Corporation for board membership.

Acknowledgements

Anna Maria Wilms Floet, MD Assistant Professor, Assistant Professor of Pediatrics, Department of Pediatrics, Behavior and Developmental, University of Maryland School of Medicine

Anna Maria Wilms Floet, MD is a member of the following medical societies: American Academy of Pediatrics and Society for Developmental and Behavioral Pediatrics

Disclosure: Nothing to disclose.

References
  1. Bleichhardt G, Hiller W. Hypochondriasis and health anxiety in the German population. Br J Health Psychol. 2007 Nov. 12:511-23. [Medline].

  2. Esposito M, Roccella M, Gallai B, Parisi L, Lavano SM, Marotta R, et al. Maternal personality profile of children affected by migraine. Neuropsychiatr Dis Treat. 2013. 9:1351-8. [Medline]. [Full Text].

  3. Walker LS, Garber J, Greene JW. Somatic complaints in pediatric patients: a prospective study of the role of negative life events, child social and academic competence, and parental somatic symptoms. J Consult Clin Psychol. 1994 Dec. 62(6):1213-21. [Medline].

  4. Rask CU, Elberling H, Skovgaard AM, Thomsen PH, Fink P. Parental-reported health anxiety symptoms in 5- to 7-year-old children: the Copenhagen Child Cohort CCC 2000. Psychosomatics. 2012 Jan-Feb. 53(1):58-67. [Medline].

  5. Schwenzer M, Mathiak K. Hypochondriacal attitudes may reflect a general cognitive bias that is not limited to illness-related thoughts. Psychol Health. 2011 Aug. 26(8):965-73. [Medline].

  6. Rask CU. Functional somatic symptoms in 5-7 year old children: assessment, prevalence and co-occurrence. Dan Med J. 2012 Nov. 59(11):B4537. [Medline].

  7. Bailer J, Witthöft M, Wagner H, Mier D, Diener C, Rist F. Childhood maltreatment is associated with depression but not with hypochondriasis in later life. J Psychosom Res. 2014 Aug. 77(2):104-8. [Medline].

  8. Noyes R Jr, Stuart S, Langbehn DR, et al. Childhood antecedents of hypochondriasis. Psychosomatics. 2002 Jul-Aug. 43(4):282-9. [Medline].

  9. Abramowitz JS, Moore EL. An experimental analysis of hypochondriasis. Behav Res Ther. 2007 Mar. 45(3):413-24. [Medline].

  10. Torres AR, Ferrão YA, Shavitt RG, Diniz JB, Costa DL, do Rosário MC, et al. Panic Disorder and Agoraphobia in OCD patients: clinical profile and possible treatment implications. Compr Psychiatry. 2014 Apr. 55(3):588-97. [Medline].

  11. Weck F, Neng JM, Richtberg S, Stangier U. The restrictive concept of good health in patients with hypochondriasis. J Anxiety Disord. 2012 Dec. 26(8):792-8. [Medline].

  12. Muse K, McManus F, Leung C, Meghreblian B, Williams JM. Cyberchondriasis: fact or fiction? A preliminary examination of the relationship between health anxiety and searching for health information on the Internet. J Anxiety Disord. 2012 Jan. 26(1):189-96. [Medline].

  13. Sakai R, Nestoriuc Y, Nolido NV, Barsky AJ. The prevalence of personality disorders in hypochondriasis. J Clin Psychiatry. 2010 Jan. 71(1):41-7. [Medline].

  14. Greeven A. van Balkom AJ. Visser S. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a control randomized trial. American Journal of Psychiatry. 2007 jan. 164(1):91-9. [Medline].

  15. Thomson AB, Page LA. Psychotherapies for hypochondriasis. Cochrane Database Syst Rev. 2007 Oct 17. CD006520. [Medline].

  16. Eilenberg T, Kronstrand L, Fink P, Frostholm L. Acceptance and commitment group therapy for health anxiety - Results from a pilot study. J Anxiety Disord. 2013 Jun. 27(5):461-8. [Medline].

  17. Sorensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011 Feb. 41(2):431-41. [Medline].

  18. Warwick HM, Clark DM, Cobb AM, Salkovskis PM. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry. 1996 Aug. 169(2):189-95. [Medline].

  19. Weck F. Treatment of Mental Hypochondriasis: A Case Report. Psychiatr Q. 2013 Aug 10. [Medline].

  20. Schweitzer PJ, Zafar U, Pavlicova M, Fallon BA. Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. J Clin Psychopharmacol. 2011 Jun. 31(3):365-8. [Medline].

  21. Undefined.

  22. Abramowitz JS, Deacon BJ. Severe health anxiety: why it persists and how to treat it. Compr Ther. 2004 Spring. 30(1):44-9. [Medline].

  23. Albrecht S, Naugle AE. Psychological assessment and treatment of somatization: adolescents with medically unexplained neurologic symptoms. Adolesc Med. 2002 Oct. 13(3):625-41. [Medline].

  24. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004 Mar 24. 291(12):1464-70. [Medline].

  25. Barsky AJ, Coeytaux RR, Sarnie MK, Cleary PD. Hypochondriacal patients' beliefs about good health. Am J Psychiatry. 1993 Jul. 150(7):1085-9. [Medline].

  26. Bouman TK, Visser S. Cognitive and behavioural treatment of hypochondriasis. Psychother Psychosom. 1998 Jul-Oct. 67(4-5):214-21. [Medline].

  27. Campo JV, Jansen-McWilliams L, Comer DM, Kelleher KJ. Somatization in pediatric primary care: association with psychopathology, functional impairment, and use of services. J Am Acad Child Adolesc Psychiatry. 1999 Sep. 38(9):1093-101. [Medline].

  28. Campo JV, Reich MD. Somatoform disorders. Netherton S, Walker CE, Holmes D, eds. Child and Adolescent Psychological Disorders: A Comprehensive Textbook. New York, NY: Oxford Univ Press; 1999. 320-43.

  29. Lewis M, ed. Child and Adolescent Psychiatry? A Comprehensive Textbook. Williams & Wilkins; 1996.

  30. Egger HL, Costello EJ, Erkanli A, Angold A. Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches. J Am Acad Child Adolesc Psychiatry. 1999 Jul. 38(7):852-60. [Medline].

  31. Escobar JI, Gara M, Waitzkin H, et al. DSM-IV hypochondriasis in primary care. Gen Hosp Psychiatry. 1998 May. 20(3):155-9. [Medline].

  32. Fallon BA, Schneier FR, Marshall R, et al. The pharmacotherapy of hypochondriasis. Psychopharmacol Bull. 1996. 32(4):607-11. [Medline].

  33. Fritz GK, Fritsch S, Hagino O. Somatoform disorders in children and adolescents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997 Oct. 36(10):1329-38. [Medline].

  34. Haugaard JJ. Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated:somatization and other somatoform disorders. Child Maltreat. 2004. May 9(2):169-76. [Medline].

  35. Hiller W, Leibbrand R, Rief W, Fichter MM. Differentiating hypochondriasis from panic disorder. J Anxiety Disord. 2005. 19(1):29-49. [Medline].

  36. Hitchcock PB, Mathews A. Interpretation of bodily symptoms in hypochondriasis. Behav Res Ther. 1992 May. 30(3):223-34. [Medline].

  37. Kellner R. Somatization and Hypochondriasis. New York, NY: Praeger-Greenwood; 1986.

  38. Lieb R, Pfister H, Mastaler M, Wittchen HU. Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand. 2000 Mar. 101(3):194-208. [Medline].

  39. Livingston R, Witt A, Smith GR. Families who somatize. J Dev Behav Pediatr. 1995 Feb. 16(1):42-6. [Medline].

  40. Longley SL, Watson D, Noyes R Jr. Assessment of the hypochondriasis domain: the multidimentional inventory of hypochondriacal traits (MIHT). Psychol Assess. 2005. Mar 17(1):3-14. [Medline].

  41. Noyes R Jr, Happel RL, Yagla SJ. Correlates of hypochondriasis in a nonclinical population. Psychosomatics. 1999 Nov-Dec. 40(6):461-9. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.